FR2642420B1 - NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID - Google Patents

NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID

Info

Publication number
FR2642420B1
FR2642420B1 FR8900993A FR8900993A FR2642420B1 FR 2642420 B1 FR2642420 B1 FR 2642420B1 FR 8900993 A FR8900993 A FR 8900993A FR 8900993 A FR8900993 A FR 8900993A FR 2642420 B1 FR2642420 B1 FR 2642420B1
Authority
FR
France
Prior art keywords
combination
form containing
galenic form
ferrous salts
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8900993A
Other languages
French (fr)
Other versions
FR2642420A1 (en
Inventor
Andre Stamm
Laurence Durupt
Sylvie Fontaine
Jean-Yves Pabst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valpan SA Labo Pharma
Original Assignee
Valpan SA Labo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valpan SA Labo Pharma filed Critical Valpan SA Labo Pharma
Priority to FR8900993A priority Critical patent/FR2642420B1/en
Publication of FR2642420A1 publication Critical patent/FR2642420A1/en
Application granted granted Critical
Publication of FR2642420B1 publication Critical patent/FR2642420B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
FR8900993A 1989-01-27 1989-01-27 NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID Expired - Fee Related FR2642420B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8900993A FR2642420B1 (en) 1989-01-27 1989-01-27 NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8900993A FR2642420B1 (en) 1989-01-27 1989-01-27 NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID

Publications (2)

Publication Number Publication Date
FR2642420A1 FR2642420A1 (en) 1990-08-03
FR2642420B1 true FR2642420B1 (en) 1991-09-06

Family

ID=9378154

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8900993A Expired - Fee Related FR2642420B1 (en) 1989-01-27 1989-01-27 NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID

Country Status (1)

Country Link
FR (1) FR2642420B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5849240A (en) 1993-11-23 1998-12-15 Euro-Celtique, S.A. Method of preparing sustained release pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5958452A (en) 1994-11-04 1999-09-28 Euro-Celtique, S.A. Extruded orally administrable opioid formulations
US6068855A (en) 1994-11-03 2000-05-30 Euro-Celtique S. A. Pharmaceutical composition containing a fusible carrier and method for producing the same
US6254887B1 (en) 1993-05-10 2001-07-03 Euro-Celtique S.A. Controlled release tramadol

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933108A (en) * 1960-02-03 1963-08-08 Haessle Ab Improvements in or relating to pharmaceutical iron preparations
JPH0729927B2 (en) * 1983-04-09 1995-04-05 日研化学株式会社 Theophylline sustained release formulation
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254887B1 (en) 1993-05-10 2001-07-03 Euro-Celtique S.A. Controlled release tramadol
US6326027B1 (en) 1993-05-10 2001-12-04 Euro-Celtique S.A. Controlled release formulation
US5849240A (en) 1993-11-23 1998-12-15 Euro-Celtique, S.A. Method of preparing sustained release pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5965163A (en) 1993-11-23 1999-10-12 Euro-Celtique, S.A. Substained release compositions and a method of preparing pharmaceutical compositions
US6162467A (en) 1993-11-23 2000-12-19 Euro-Celtique, S.A. Sustained release compositions and a method of preparing pharmaceutical compositions
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US6068855A (en) 1994-11-03 2000-05-30 Euro-Celtique S. A. Pharmaceutical composition containing a fusible carrier and method for producing the same
US5958452A (en) 1994-11-04 1999-09-28 Euro-Celtique, S.A. Extruded orally administrable opioid formulations
US6261599B1 (en) 1994-11-04 2001-07-17 Euro-Celtique, S.A. Melt-extruded orally administrable opioid formulations
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6335033B2 (en) 1994-11-04 2002-01-01 Euro-Celtique, S.A. Melt-extrusion multiparticulates
US6706281B2 (en) 1994-11-04 2004-03-16 Euro-Celtique, S.A. Melt-extrusion multiparticulates

Also Published As

Publication number Publication date
FR2642420A1 (en) 1990-08-03

Similar Documents

Publication Publication Date Title
FR2457511B1 (en) PHOTOPOLYMERIZABLE COMPOSITIONS CONTAINING IODONIUM OR SULFONIUM SALTS
FR2737122B1 (en) STABLE COMPOSITION CONTAINING ASCORBIC ACID
MA21749A1 (en) PROCESS OF COMPOSITIONS OF DEODORANT CONTAINING CERTAIN SALTS OF PIROCTONIC ACID AND PERFUMES.
FR2596758B1 (en) IMPROVED PHARMACEUTICAL SALTS OF AMLODIPINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2643556B1 (en) PHARMACEUTICAL COMPOSITION WITH SUSTAINED RELEASE OF VALPROIC ACID
DE69010139D1 (en) Hair restorative.
FR2582513B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
PT99445A (en) PROCESS FOR THE PREPARATION OF MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODEAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK232989D0 (en) ANTIVIRAL PREPARATION
OA09227A (en) "Cephalosporin salts, mixtures containing these salts and method of preparing the sulfuric acid addition salt".
FR2642420B1 (en) NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID
FR2582306B1 (en) N-ACYL-THIAZOLIDINE-4-CARBOXYLIC ACID SALTS AND 6-PIPERIDINO-2,4-DIAMINOPYRIMIDINE-3-OXIDE AND COSMETIC-DERMATOLOGICAL COMPOSITIONS CONTAINING THE SAME
FR2688506B1 (en) PROCESS FOR THE PREPARATION OF SALTS OF CLAVULANIC ACID.
FR2668464B1 (en) MIXED YTTRIUM AND LANTHANIDE SILICATES AND LASER USING SINGLE CRYSTALS OF THESE SILICATES.
ES2055235T3 (en) ANTI-INFLAMMATORY AND / OR ANTI-ALLERGIC COMPOSITION THAT INCLUDES DERIVATIVES OF GLUTATION.
FR2557454B1 (en) COMPOSITION BASED ON POLYVINYLPHOSPHONIC ACID OR A SALT THEREOF FOR INHIBITING DENTAL PLATE AND GINGIVITIS
IE870130L (en) Substituted 4-amino-3-hydroxybutyric acid derivatives,¹processes for their preparation, agents containing these¹compounds and their use
MX171542B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEOXYRIBONUCLEOSIDES FOR WOUND HEALING
FR2579228B1 (en) AQUEOUS COMPOSITION FOR THE PASSIVATION OF ZINC-COBALT ALLOYS AND PROCESS FOR THE PASSIVATION OF SUCH ALLOYS
FR2712590B1 (en) New derivatives of kojic acid.
AU576926B2 (en) Tetrazole derivatives
FR2559151B1 (en) ARGININ DERIVATIVES AND ADDED SALTS OF CORRESPONDING PHARMACEUTICALLY ACCEPTABLE ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE3877277T2 (en) INJECTION COMPOSITION CONTAINING MODIFIED TPA.
FI841369A (en) PH-OBEROENDE, KONTROLLERAT FRIGOERANDE TABLETT.
MA23133A1 (en) DERIVATIVES OF ACYLOXYHEXANOIC ACID.

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property
ST Notification of lapse